Skip to content
DataLookout
Menu

NCT05776706

Clinical Trial for the Validation of AR Based Neuronavigation System

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 7 more changesShow less
    • Primary endpoint(s) modified
    • Start date changed from estimate of May 1, 2025 to Sep 8, 2026
    • Eligibility criteria expanded, about 41 words
    • Interventions modified
    • Study sites: 1 to 2
    • Secondary endpoints: 3 to 4
    • Study description expanded, about 2 words
  2. Notable Start date: Jun 1, 2023 to May 1, 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    • Site details revised
    v3
  3. Notable Start date: Apr 1, 2023 to Jun 1, 2023v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Target Registration Error (TRE) of AR-based navigation at anatomical landmarks
Timeframe: Intraoperative, immediately after AR registration before surgical draping on the day of surgery
Registration time of AR-based navigation
Timeframe: Intraoperative, on the day of surgery

Secondary (4)

Post-drape TRE after QR marker-based registration restoration
Incidence of registration drift after draping
Adverse events and device malfunctions
One-step processing time from CT acquisition to 3D model delivery (SNUH only)

Arms and interventions

Single armExperimental

We will set up 2 navigation systems, newly developed AR-based navigation and conventional navigation system, to surgeries of all participants. Surgeons will perform all surgical planning and operations with reference to the conventional navigation system. In this process, the errors of the existing navigation and the newly developed navigation will be measured and compared in 3D at several points, and the points are as follows: 1. Fiducial markers 2. Nasion 3. Tumor's margin (anterior, posterior, superior, inferior)

Devices: AR-based navigation

Sites

2 sites in 1 country